#UPDATE | #Covid-19 #Vaccine - More than 150 vaccines are being developed and tested around the world to stop the COVID-19 pandemic, with 25 in human clinical trials, according to the World Health Organization.
The following list tracks the latest developments from major drugmakers and research institutes that have started human trials for their vaccine candidates.
UNITED KINGDOM (3)
▪️AztraZeneca Plc
DEVELOPMENT PHASE: Final stage study in 1,077 healthy adults
STATE OF PLAY:
- Vaccine produces immune response in early-stage trials
- Late-stage trials currently underway in adults in Brazil and South Africa and due to start in US.
- Over a million doses possible by September.
▪️GlaxoSmithKline Plc
DEVELOPMENT PHASE: Early stage trials to begin September
STATE OF PLAY
- Partnered with Sanofi SA to develop a vaccine
▪️Imperial College London
DEVELOPMENT PHASE: Early-stage trials
STATE OF PLAY:
- Scientists at Imperial College London are running trials of a potential coronavirus vaccine.
CHINA (7)
▪️Sinopharm
DEVELOPMENT PHASE: Final stage trials in Abu Dhabi, testing up to 15,000 volunteers
STATE OF PLAY:
- The Chinese state-owned company is developing two vaccines, one of which has shown promise in humans.
▪️ Sinovac Biotech Ltd
DEVELOPMENT PHASE: Final-stage trials
STATE OF PLAY:
- The China-based vaccine maker has released positive preliminary results from early-stage trials of its vaccine
▪️ CanSino Biologics
DEVELOPMENT PHASE: Mid-stage trial
STATE OF PLAY:
- Early results showed the China-based company's vaccine is safe
- China's military has received the greenlight to use the vaccine.
▪️Chinese Academy of Medical Sciences
DEVELOPMENT PHASE: Mid-stage trials
STATE OF PLAY:
-Researchers at Institute of Medical Biology are testing a coronavirus vaccine
▪️ Chongqing Zhifei Biological Products
DEVELOPMENT PHASE: Mid-stage trial
STATE OF PLAY:
- The Chinese company's unit Anhui Zhifei Longcom Biopharmaceutical has begun human trials
▪️Clover Biopharmaceuticals
DEVELOPMENT PHASE: Early-stage trials
STATE OF PLAY:
- The Chinese developer received $66 million in investments from an epidemic response group
▪️Walvax Biotechnology Co
DEVELOPMENT PHASE: Early-stage studies
STATE OF PLAY:
- Trials sponsored by the China-based company, along with a Chinese military research institute, have begun
UNITED STATE OF AMERICA (7)
▪️Pfizer Inc and BioNtech SE
DEVELOPMENT PHASE: Begins pivotal global study to evaluate lead COVID-19 vaccine candidate; Study aims to enroll 30,000 volunteers
STATE OF PLAY:
- Vaccine produced virus-neutralizing antibodies in early-stage trials in U.S. and Germany
- Pfizer aims for about 1.3 billion doses by the end of 2021
▪️Moderna Inc
DEVELOPMENT PHASE: 30,000 subject final stage trial to demonstrate it is safe and effective began in July 27
STATE OF PLAY:
- Vaccine could be ready for widespread use by end of 2020
- company says on track to deliver up to 1 billion doses a year, beginning 2021
▪️Inovio Pharma
DEVELOOMENT PHASE: Mid-stage testing
STATE OF PLAY:
- Vaccine candidate, found to be safe, induced Immune responses in healthy volunters in an early stage study
▪️Johnson & Johnson
DEVELOPMENT PHASE: Early stage trials to start in July, late -stage study planned for September
STATE OF PLAY:
- In talks with Japan, Bill and Melinda Gates Foundation, and the European Union for vaccine allocations
▪️Novovax Inc
DEVELOPMENT PHASE: Early-stage testing
STATE OF PLAY:
- The U.S government has awarded $1.6 billion to test and manufacture its experimental vaccine
▪️Arcturus Therapeutics and Duke-NUS
DEVELOPMENT PHASE: Early-stage testing
STATE OF PLAY:
- Gets approval to begin clinical trials for its COVID-19 vaccine candidate, LUNAR-COV19
▪️Kentucky Bioprocessing Inc
DEVELOPMENT PHASE: Early-stage testing
STATE OF PLAY:
-Experts to begin trial of vaccine candidate in 180 adults on July 31
INDIA (2)
▪️Bharat Biotech
DEVELOPMENT PHASE: Early-to mid- stage trials to start in July
STATE OF PLAY:
- Vaccine approved for human trials in India
▪️Cadila Healthcare Ltd
DEVELOPMENT PHASE: Early-stage trials
STATE OF PLAY:
- Plans to finish late-stage trials by early 2021
AUSTRALIA (2)
▪️University of Queensland
DEVELOPMENT PHASE: Early-stage testing
STATE OF PLAY:
- University of Queensland began human trials in collabiration with Australian biotech company CSI
▪️Vaxine Pty Ltd/Medytox
DEVELOPMENT PHASE: Early-stage testing
STATE OF PLAY:
-Australian biotech expects to start mid-stage trials in next few weeks after positive results from the first stage human study
GERMANY
▪️CureVac
DEVELOPMENT PHASE: Early -stage trial
STATE OF PLAY:
- German biotech expects data in September or October, files for IPO in U.S
SOUTH KOREA
▪️Genexine Inc
DEVELOPMENT PHASE: Early-stage trials
STATE OF PLAY:
- South Korea's Genexine has begun human trials in South Korea
RUSSIA
▪️Gamaleya Research Institute
DEVELOPMENT PHASE: Early-stage trials
STATE OF PLAY:
- The Gamaleya Research Institute has begun human trials of an experimental vaccine, with results expected in August
CANADA
▪️Medicago
DEVELOPMENT PHASE: Early-stage trials
STATE OF PLAY:
- The Canadian company is studying a plant-based vaccine
JAPAN
▪️Osaka University AnGes, Takara Bio
DEVELOPMENT PHASE: Early-stage testing
STATE OF PLAY:
- A single-center trial in 30 healthy volunteers
TAIWAN
▪️ Medigen Vaccine Biologics Corp/NIAID/Dynavax
DEVELOPMENT PHASE: Expects to begin early-stage in 45 people on Sept. 1. Not yet recruiting
Source: Reuters
Comments
Post a Comment